+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

Escin IA

BP0556
123748-68-5
98%
Phytounique
Escin IA is a prodrug and its structure can be converted to desacylescin I by human intestinal bacteria and Lactobacillus brevis., desacylescin I as a biotransformation product shows potentially inhibitory effects on mouse tumor, and a potential candidate for anti tumor agents. Escin IA has anti-TNBC metastasis activity, and its action mechanisms involved inhibition of EMT process by down-regulating LOXL2 expression.
Catalog No Package Original Price Price Inventory Quantity Operating
BP0556-20mg 20mg
BP0556-100mg 100mg
Chengdu Biopurify Phytochemicals Ltd.
Chengdu Biopurify Phytochemicals Ltd.

Related targets

RELA TNF NOS2 PTGS2 NFKB1 IL6 IL1B
NOS3 EDNRA ELANE MMP9 PDE5A HTR2A ICAM1 VEGFA VWF
RELA MMP9 NFKB1 CTNNB1 CDH1 VEGFA
TNF NOS2 MPO PTGS2 IL1B SOD1 HMOX1

Escin IA Related Products

Product drug property prediction parameters

  • 388.0400

  • 1.2339

  • -1.2841

  • .3700

  • .4702

  • .1872

  • Low

  • 73.6520

  • 6.9877

  • No

  • No

  • No

  • No

  • No

  • No

  • 0.0

  • Yes

  • No

  • Yes

  • Yes